This may help regulate hormones in conditions like insulin resistance or PCOS, but it is not a hormone therapy and does not directly balance estrogen or progesterone
Recognising these realities is essential before committing to GLP-1-based treatment
Int J Drug Deliv 3(2):381385 Bhatia D, Ardekani MS, Shi Q, Movafagh S (2017) Hypoxia and its emerging therapeutics in neurodegenerative, inflammatory and renal diseases
In a 14-week animal study, GlucoVantage achieved peak GLP-1 increases of 165% at the 14-week mark , while delivering 33.3% body weight reduction by week 13 compared to high-fat diet controls
"If taking medications that decrease appetite or insulin requirements, people with type 1 diabetes still must continue taking their long-acting insulin or using their insulin pump." Semaglutide, vomiting, and DKA: A case study In a 2023 case report, a person with type 1 arrived at an emergency room with ketoacidosis, after suffering nausea and vomiting attributed to taking Wegovy (semaglutide) prescribed by his endocrinologist for weight loss
Sterry W, Ortonne JP, Kirkham B, et al
.png)
